Clinical Trial Detail

NCT ID NCT00267865
Title Chemotherapy and HAART to Treat AIDS-related Primary Brain Lymphoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements no
Sponsors National Cancer Institute (NCI)
Indications

central nervous system lymphoma

Therapies

Rituximab

Methotrexate

Leucovorin

Age Groups: adult

No variant requirements are available.